Eleni Rettig

9PUBLICATIONS
49CO-AUTHORS
Predictive and prognostic markersRadiation therapyCancer therapy (excl. chemotherapy and radiation therapy)Oral and maxillofacial surgeryCancer genetics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Dec 23, 2024
A Prospective Trial of Biomarker-Guided Surveillance for HPV-Positive Oropharynx Cancer Using Plasma Tumor Tissue-Modified Viral HPV DNA.

Eleni M Rettig, Jonathan D Schoenfeld, Julianna Miller

|Jun 02, 2024
Personalized ctDNA for Monitoring Disease Status in Head and Neck Squamous Cell Carcinoma.

Glenn J Hanna, Michael J Dennis, Nicole Scarfo

|Aug 11, 2023
Negative Predictive Value of Circulating Tumor Tissue Modified Viral (TTMV)-HPV DNA for HPV-driven Oropharyngeal Cancer Surveillance.

Glenn J Hanna, Scott A Roof, Jamie Jabalee

|Mar 31, 2022
Association between radiation dose to organs at risk and acute patient reported outcome during radiation treatment for head and neck cancers.

Mona Arbab, Yu-Hui Chen, Roy B Tishler

|Mar 09, 2022
Detection of circulating tumor human papillomavirus DNA before diagnosis of HPV-positive head and neck cancer.

Eleni M Rettig, Daniel L Faden, Shaiba Sandhu

|Oct 20, 2021
Neoadjuvant and Adjuvant Nivolumab and Lirilumab in Patients with Recurrent, Resectable Squamous Cell Carcinoma of the Head and Neck.

Glenn J Hanna, Anne O'Neill, Kee-Young Shin

Pageof 2

Frequent Collaborators

4 joint publications

Glenn J Hanna

4 joint publications

Jonathan D Schoenfeld

3 joint publications

Danielle N Margalit

3 joint publications

Roy B Tishler